Terms: = Breast cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Prognosis
50 results:
1. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
[TBL] [Abstract] [Full Text] [Related]
2. A retrospective validation of CanAssist breast in European early-stage breast cancer patient cohort.
Gunda A; Basavaraj C; Serkad V CP; Adinarayan M; Kolli R; Siraganahalli Eshwaraiah M; Saura C; Ruiz F; Gomez P; Peg V; Jimenez J; Sprung S; Fiegl H; Brunner C; Egle D; Bhattacharyya GS; Bakre MM
Breast; 2022 Jun; 63():1-8. PubMed ID: 35245746
[TBL] [Abstract] [Full Text] [Related]
3. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.
Borchmann S; Joffe E; Moskowitz CH; Zelenetz AD; Noy A; Portlock CS; Gerecitano JF; Batlevi CL; Caron PC; Drullinsky P; Hamilton A; Hamlin PA; Horwitz SM; Kumar A; Matasar MJ; Moskowitz AJ; Owens CN; Palomba ML; Younes A; Straus DJ
Blood; 2019 May; 133(20):2121-2129. PubMed ID: 30770396
[TBL] [Abstract] [Full Text] [Related]
4. Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data.
Kim YJ; Kim K
Breast; 2017 Apr; 32():26-32. PubMed ID: 28013032
[TBL] [Abstract] [Full Text] [Related]
5. [Role of eukaryotic translation initiation factor 4G in tumor].
Zhang S; Huang N; Pan X; Zang JL; Guan XX; Zhang JH; Liu LC; Lei XY
Sheng Li Xue Bao; 2016 Apr; 68(2):207-14. PubMed ID: 27108909
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics and survival analysis of 22 cases of pure epithelial breast metaplastic carcinoma].
Meng HM; Yang YF; Qi LQ; Gu L
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):525-9. PubMed ID: 24257306
[TBL] [Abstract] [Full Text] [Related]
7. Downregulation of eif4a2 in non-small-cell lung cancer associates with poor prognosis.
Shaoyan X; Juanjuan Y; Yalan T; Ping H; Jianzhong L; Qinian W
Clin Lung Cancer; 2013 Nov; 14(6):658-65. PubMed ID: 23867391
[TBL] [Abstract] [Full Text] [Related]
8. breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes?
Bai HX; Motwani SB; Higgins SA; Haffty BG; Wilson LD; Lannin DR; Evans SB; Moran MS
Int J Clin Oncol; 2014; 19(3):460-6. PubMed ID: 23780727
[TBL] [Abstract] [Full Text] [Related]
9. eif4f suppression in breast cancer affects maintenance and progression.
Nasr Z; Robert F; Porco JA; Muller WJ; Pelletier J
Oncogene; 2013 Feb; 32(7):861-71. PubMed ID: 22484424
[TBL] [Abstract] [Full Text] [Related]
10. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.
Yan LX; Wu QN; Zhang Y; Li YY; Liao DZ; Hou JH; Fu J; Zeng MS; Yun JP; Wu QL; Zeng YX; Shao JY
Breast Cancer Res; 2011 Jan; 13(1):R2. PubMed ID: 21219636
[TBL] [Abstract] [Full Text] [Related]
11. Metabolic profile, physical activity, and mortality in breast cancer patients.
Emaus A; Veierød MB; Tretli S; Finstad SE; Selmer R; Furberg AS; Bernstein L; Schlichting E; Thune I
Breast Cancer Res Treat; 2010 Jun; 121(3):651-60. PubMed ID: 19882245
[TBL] [Abstract] [Full Text] [Related]
12. The influence of cosmetic breast augmentation on the stage distribution and prognosis of women subsequently diagnosed with breast cancer.
Xie L; Brisson J; Holowaty EJ; Villeneuve PJ; Mao Y
Int J Cancer; 2010 May; 126(9):2182-90. PubMed ID: 19569048
[TBL] [Abstract] [Full Text] [Related]
13. Trends for inflammatory breast cancer: is survival improving?
Gonzalez-Angulo AM; Hennessy BT; Broglio K; Meric-Bernstam F; Cristofanilli M; Giordano SH; Buchholz TA; Sahin A; Singletary SE; Buzdar AU; Hortobágyi GN
Oncologist; 2007 Aug; 12(8):904-12. PubMed ID: 17766649
[TBL] [Abstract] [Full Text] [Related]
14. Coexistence of pregnancy and cancer.
Jacobs IA; Chang CK; Salti GI
Am Surg; 2004 Nov; 70(11):1025-9. PubMed ID: 15586520
[TBL] [Abstract] [Full Text] [Related]
15. Is breast cancer survival improving?
Giordano SH; Buzdar AU; Smith TL; Kau SW; Yang Y; Hortobagyi GN
Cancer; 2004 Jan; 100(1):44-52. PubMed ID: 14692023
[TBL] [Abstract] [Full Text] [Related]
16. prognosis of bilateral synchronous breast cancer in Vaud, Switzerland.
Levi F; Randimbison L; Te VC; La Vecchia C
Breast; 2003 Apr; 12(2):89-91. PubMed ID: 14659336
[TBL] [Abstract] [Full Text] [Related]
17. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years.
Li CI; Moe RE; Daling JR
Arch Intern Med; 2003 Oct; 163(18):2149-53. PubMed ID: 14557212
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
[TBL] [Abstract] [Full Text] [Related]
19. Second malignancies after Hodgkin's disease: the Munich experience.
Munker R; Grützner S; Hiller E; Aydemir U; Enne W; Dietzfelbinger H; Busch M; Haas R; Emmerich B; Schmidt M; Dühmke E; Hölzel D; Wilmanns W
Ann Hematol; 1999 Dec; 78(12):544-54. PubMed ID: 10647878
[TBL] [Abstract] [Full Text] [Related]
20. [prognosis of breast carcinoma after Rotter-Halsted operation. 10-year outcome in 240 patients].
Braun L
Zentralbl Chir; 1998; 123 Suppl 5():90-3. PubMed ID: 10063583
[TBL] [Abstract] [Full Text] [Related]
[Next]
